检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:张慧明[1] 邹小明[1] 张天华[1] 曹守强[1] 秦华东[1] 张建国[1] 周文学[1]
机构地区:[1]哈尔滨医科大学第二临床医学院普外二科,黑龙江哈尔滨150086
出 处:《哈尔滨医科大学学报》2004年第5期446-448,共3页Journal of Harbin Medical University
摘 要:目的 探讨在大鼠同种肝移植排斥反应中重组人白细胞介素 10 (rhIL 10 )对肿瘤坏死因子 α(TNF α)及白细胞介素 2 (IL 2 )的影响。方法 供体为ACI(RTIα)大鼠 ,受体为LEW (RTI1 )大鼠。实验组大鼠在移植前后腹腔注射 10 μg kg·drhIL 10。对照组腹腔内注射 0 .85 %等量生理盐水 ,注射时间同实验组。用免疫组化方法观察肝脏组织中TNF α及IL 2的改变。结果 实验组大鼠平均存活时间 (13.0± 1.0 )d ,与对照组 (9.4± 0 .7)d相比 ,有非常显著性意义 (P <0 .0 0 1) ;移植后各时间点实验组比对照组肝组织破坏程度减轻 ,TNF α阳性率明显小于对照组 (P <0 .0 1) ,IL 2阳性率显著小于对照组 (P <0 .0 0 1)。结论 rhIL 10能够降低大鼠移植肝组织中IL 2和TNF α的表达 ,减轻排斥反应 ,延长移植物的存活时间 ,表明rhIL 10对肝移植有积极的作用。Objective To investigate the role of recombinant human interleukin-10(rhIL-10) in acute rejection in rats after orthotopic liver homeo transplantation.Methods ACI(RTIα) rats and LEW(TRI1) rats were used as donors and receptors,respectively.Treated group received injections of rhIL-10 at dose of 10μg/kg·d pre- and post-transplantation.Control group received the same dose of 0.85% sodium chloride,the injection time was the same with the treated group and the change of IL-2 and TNF-α in the liver tissue was measured with immunohistochemical method.Results The mean survival time of treated group(13.0±1.0)d was much longer than that of control group(9.4±0.7)d(P<0.001).The average concentration of IL-2(P<0.001) and TNF-α(P<0.01) in the hepatic tissue of treated group decreased obviously compared with the control group.The grade of liver injures in treated group after transplantation was less than that of control group.Conclusion rhIL-10 can decrease expression of IL-2 and TNF-α,relieve the severity of acute rejection after liver transplantation and prolong the survival time of grafts.And these results show that rhIL-10 therapy is useful in liver transplantation.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.145